No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
KFY240517P50000
- 0.10
- 0.000.00%
15min DelayTrading Apr 16 14:01 ET
0.00High0.00Low
0.00Open0.10Pre Close0 Volume2 Open Interest50.00Strike Price0.00Turnover178.57%IV-24.09%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type-0.0258Delta0.0062Gamma657.40Leverage Ratio-0.0834Theta-0.0001Rho-16.95Eff Leverage0.0033Vega
Intraday
- 5D
- 1D
News
Is Korn Ferry (NYSE:KFY) Expensive For A Reason? A Look At Its Intrinsic Value
Korn Ferry Ranked as America's Best Executive Recruiter by Forbes Magazine
Company Also Named a Top Professional Search FirmLOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) has been recognized by Forbes Magazine as America's best executive recruiting firm – a top ranking
Simmons Bank Open for the Snedeker Foundation Relocating to Vanderbilt Legends Club Beginning 2024
Korn Ferry Tour (PRNewsfoto/Simmons Bank) Simmons Bank Open for the Snedeker Foundation (PRNewsfoto/Simmons Bank)
Should You Investigate Korn Ferry (NYSE:KFY) At US$61.01?
Korn Ferry (NYSE:KFY), is not the largest company out there, but it saw significant share price movement during recent months on the NYSE, rising to highs of US$66.14 and falling to the lows of U
At US$62.65, Is It Time To Put Korn Ferry (NYSE:KFY) On Your Watch List?
Korn Ferry (NYSE:KFY) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Comments
Investors' expectations of strong future growth justify Korn Ferry's high P/E ratio. The potential for a deterioration in earnings is not seen as significant enough to warrant a lower P/E ratio.
Getting In Cheap On Korn Ferry (NYSE:KFY) Might Be DifficultKorn Ferry's reinvestment accompanied by falling return prompts analysts to believe investors are considering this. They suggest seeking multi-bagger opportunities elsewhere.
$Market Beating Value ETF(PFL1021127)$
My paperfolio’s link can be seen above. The stocks I pick are based on value investing philosophy. I won’t go into what that means in this post. I’m a lot more conservative than your average investor. As such, this portfolio only used 50-60% of its cash to buy stocks, while the rest sat idle. In other words, I am up 13% at the time of writing mostly using only 50-75% of my portfolio’s cash (with some exceptions). As I have seen bu...
My paperfolio’s link can be seen above. The stocks I pick are based on value investing philosophy. I won’t go into what that means in this post. I’m a lot more conservative than your average investor. As such, this portfolio only used 50-60% of its cash to buy stocks, while the rest sat idle. In other words, I am up 13% at the time of writing mostly using only 50-75% of my portfolio’s cash (with some exceptions). As I have seen bu...
8
Gainers:
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
Read more